BMC Cancer 2008, 8:270 http://www.biomedcentral.com/1471-2407/8/270 expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 4. Yehiely F, Moyano JV, Evans JR, Nielsen TO, Cryns VL: Decon- structing the molecular portrait of basal-like breast cancer. Trends Mol Med 2006, 12:537-544. 5. van 't Veer LJ, Dai H, Vijver MJ van de, He YD, Hart AA, Mao M, Peterse HL, Kooy K van der, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast can- cer. Nature 2002, 415:530-536. 6. Perou CM, Sorlie T, Eisen MB, Rijn M van de, Jeffrey SS, Rees CA, Pol- lack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Bot- stein D: Molecular portraits of human breast tumors. Nature 2000, 406:747-752. 7. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ: Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003, 100:15901-15905. 8. Solakoglu O, Maierhofer C, Lahr G, Breit E, Scheunemann P, Heumos I, Pichlmeier U, Schlimok G, Oberneder R, Kollermann MW, Koller- mann J, Speicher MR, Pantel K: Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc Natl Acad Sci USA 2002, 99:2246-2251. 9. Whitfield ML, George LK, Grant GD, Perou CM: Common mark- ers of proliferation. Nat Rev Cancer 2006, 6:99-106. 10. Ein-Dor L, Kela I, Getz G, Givol D, Domany E: Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 2005, 21:171-178. 11. Dressman HK, Hans C, Bild A, Olson JA, Rosen E, Marcom PK, Liotcheva VB, Jones EL, Vujaskovic Z, Marks J, Dewhirst MW, West M, Nevins JR, Blackwell K: Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 2006, 12:819-826. 12. de Mascarel I, MacGrogan G, Mathoulin-Pelissier S, Soubeyran I, Picot V, Coindre JM: Breast ductal carcinoma in situ with microinva- sion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 2002, 94:2134-2142. 13. Iavnilovitch E, Cardiff RD, Groner B, Barash I: Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int J Cancer 2004, 112:607-619. 14. Eilon T, Groner B, Barash I: Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females. Int J Cancer 2007, 121:1892-1902. 15. Lotem J, Netanely D, Domany E, Sachs L: Human cancers overex- press genes that are specific to a variety of normal human tissues. Proc Natl Acad Sci USA 2005, 102:18556-18561. 16. Iavnilovitch E, Groner B, Barash I: Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol Cancer Res 2002, 1:32-47. 17. Lauren PD: Algorithm to model gene expression on Affyme- trix chips without the use of MM cells. IEEE Trans Nanobioscience 2003, 2:163-170. 18. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lem- picki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 19. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868. 20. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687. 21. Givant-Horwitz V, Davidson B, Reich R: Laminin-induced signal- ing in tumor cells: the role of the M(r) 67,000 laminin recep- tor. Cancer Res 2004, 64:3572-3579. 22. Williams TM, Cheung MW, Park DS, Razani B, Cohen AW, Muller WJ, Di Vizio D, Chopra NG, Pestell RG, Lisanti MP: Loss of caveo- lin-1 gene expression accelerates the development of dys- plastic mammary lesions in tumor-prone transgenic mice. Mol Biol Cell 2003, 14:1027-1042. 23. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC: Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 1998, 4:1873-1880. 24. Pinilla SM, Honrado E, Hardisson D, Benitez J, Palacios J: Caveolin-1 expression is associated with a basal-like phenotype in spo- radic and hereditary breast cancer. Breast Cancer Res Treat 2006, 99:85-90. 25. Eynden GG Van den, Auwera I Van der, Van Laere S, Colpaert CG, van Dam P, Merajver S, Kleer CG, Harris AL, Van Marck EA, Dirix LY, Vermeulen PB: Validation of a tissue microarray to study dif- ferential protein expression in inflammatory and non-inflam- matory breast cancer. Breast Cancer Res Treat 2004, 85:13-22. 26. Savage K, Lambros MB, Robertson D, Jones RL, Jones C, Mackay A, James M, Hornick JL, Pereira EM, Milanezi F, Fletcher CD, Schmitt FC, Ashworth A, Reis-Filho JS: Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast car- cinomas: a morphologic, ultrastructural, immunohisto- chemical, and in situ hybridization analysis. Clin Cancer Res 2007, 13:90-101. 27. Sagara Y, Mimori K, Yoshinaga K, Tanaka F, Nishida K, Ohno S, Inoue H, Mori M: Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer. Br J Cancer 2004, 91:959-965. 28. Franco SJ, Huttenlocher A: Regulating cell migration: calpains make the cut. J Cell Sci 2005, 118:3829-3838. 29. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA: Focal adhe- sion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 2000, 19:5606-5613. 30. Turashvili G, Bouchal J, Burkadze G, Kolar Z: Wnt signaling path- way in mammary gland development and carcinogenesis. Pathobiology 2006, 73:213-223. 31. Karasawa T, Yokokura H, Kitajewski J, Lombroso PJ: Frizzled-9 is activated by Wnt-2 and functions in Wnt/beta-catenin sign- aling. J Biol Chem 2002, 277:37479-37486. 32. Behrens J: Cross-regulation of the Wnt signalling pathway: a role of MAP kinases. J Cell Sci 2000, 113:911-919. 33. Shi W, Harris AL: Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mam- mary Gland Biol Neoplasia 2006, 11:41-52. 34. Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K, Man- dinova A, Raffoul W, Fiche M, Dotto GP, Brisken C: Increased Wnt signaling triggers oncogenic conversion of human breast epi- thelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci USA 2006, 103:3799-3804. 35. Haines N, Irvine KD: Glycosylation regulates Notch signalling. Nat Rev Mol Cell Biol 2003, 4:786-797. 36. Visan I, Tan JB, Yuan JS, Harper JA, Koch U, Guidos CJ: Regulation of T lymphopoiesis by Notch1 and Lunatic fringe-mediated competition for intrathymic niches. Nat Immunol 2006, 7:634-643. 37. Licona-Limon P, Soldevila G: The role of TGF-beta superfamily during T cell development: new insights. Immunol Lett 2007, 109:1-12. 38. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700. 39. Shimada M, Nakanishi M: DNA damage checkpoints and cancer. J Mol Histol 2006, 37:253-260. 40. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G: Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004, 2:2825-2837. 41. Lukas J, Lukas C, Bartek J: Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair 2004, 3:997-1007. 42. Phelps DE, Hsiao KM, Li Y, Hu N, Franklin DS, Westphal E, Lee EY, Xiong Y: Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression dur- ing myogenesis. Mol Cell Biol 1998, 18:2334-2343. 43. Burchell JM, Mungul A, Taylor-Papadimitriou J: O-linked glycosyla- tion in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia 2001, 6:355-364. 44. Brockhausen I: Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999, 1473:67-95. 45. Mitra SK, Hanson DA, Schlaepfer DD: Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005, 6:56-68. Page 18 of 19 (page number not for citation purposes)